HOME >> BIOLOGY >> NEWS
Cells re-energize to come back from the brink of death

The discovery of how some abnormal cells can avoid a biochemical program of self-destruction by increasing their energy level and repairing the damage, is giving investigators at St. Jude Children's Research Hospital insights into a key strategy cancer cells use to survive and thrive.

The finding offers an explanation of how abnormal cells that have cheated death once by disabling the main suicide pathway called apoptosis can also foil a backup self-destruct program, which allows them to survive and become cancerous.

The St. Jude study also suggests that a drug that disrupts a cancer cells ability to block this backup program would allow that program to kill the cell. Such a specifically targeted drug might be more effective and less toxic than standard chemotherapy. A report on this work is in the June 1 issue of Cell.

Apoptosis is triggered by a variety of factors, including gene mutations that can make the cell become cancerous. During apoptosis, the membrane covering the cells mitochondria develop holes and leak a molecule called cytochrome c, which triggers the activity of enzymes called caspases. In turn, caspases trigger a series of events that kills the cell. Mitochondria are tiny structures that act as power plants to supply the cell with energy, but also hold the keys to the cells life and death.

The process by which the membranes develop holesmitochondrial outer membrane permeability (MOMP)is often the point of no return for self-destruction, said Douglas Green, Ph.D., chair of the St. Jude Immunology department and the studys senior author. MOMP triggers apoptosis, but if apoptosis fails because there is no caspase available, the backup program called caspase-independent cell death (CICD) takes over the process.

Previous research has shown that cells that become cancerous lack caspase and other proteins needed to support apoptosis after MOMP releases cytochrome c. But this victory over death is sho
'"/>

Contact: Summer Freeman
summer.freeman@stjude.org
901-495-3061
St. Jude Children's Research Hospital
1-Jun-2007


Page: 1 2

Related biology news :

1. Cells take risks with their identities
2. Need oxygen? Cells know how to spend and save
3. Cells selectively absorb short nanotubes
4. Cells use noise to make cell-fate decisions
5. Cells in the lung clear the air to prevent lung damage
6. Cells passed from mother to child during pregnancy live on and make insulin
7. Cells, dyes and videotape: Online scientific methods journal incorporates multimedia
8. Cells use mix-and-match approach to tailor regulation of genes
9. Cells in mucus from lungs of high-risk patients can predict tumor development
10. Double-trouble: Cells with duplicate genomes can trigger tumors
11. Double trouble: Cells with duplicate genomes can trigger tumors

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/30/2020)... (PRWEB) , ... January 30, 2020 , ... Accelera ... an eye on the Canadian market, is pleased to announce that the company has ... growth since the company launched in 2017. , “We are so thrilled to ...
(Date:1/28/2020)... ... January 28, 2020 , ... Blue Health Intelligence (BHI) ... cost of care, and limit the utilization of high-cost imaging and surgeries for ... San Antonio, Texas specializes in improving care delivery for MSK conditions. In an ...
(Date:1/24/2020)... ANGELES (PRWEB) , ... January 24, 2020 , ... ... Release Technology President Dr. Stanley Stanbridge and Vice President of Sales and Marketing ... on Fox Business Network as sponsored content on Sunday, Jan. 26, 2020 at 5:30 ...
Breaking Biology News(10 mins):
(Date:1/28/2020)... ... January 28, 2020 , ... Today, Salimetrics ... . The new Salivary Total Human IgG Assay Kit exemplifies Salimetrics’ ... in saliva, researchers can extend the accuracy and ease of use of salivary ...
(Date:1/27/2020)... RALEIGH, N.C. (PRWEB) , ... January 27, 2020 ... ... technology, today announced it has secured financing from strategic investors led by ... additional participation from existing investors Sonion, TDF Ventures, GII LLC, and WSJ Joshua ...
(Date:1/24/2020)... , ... January 24, 2020 , ... ... created by companies in biotechnology, diagnostics, therapeutics, laboratory and clinical services during the ... of people around the world. And as Slone Partners celebrates its ...
(Date:1/23/2020)... (PRWEB) , ... January 22, 2020 , ... ... new developments in the cosmetic surgery industry at two recent North American investor ... investors at the Canaccord Genuity Medical Technologies & Diagnostics Forum on November 21, ...
Breaking Biology Technology:
Cached News: